Satellos Bioscience Inc. (MSLE) Free cash flow 2024–2025
Satellos Bioscience Inc. (MSLE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.6MFY2025 · since FY2024: -$18.3M → -$23.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.6M | -29.3% |
| FY2024 | -$18.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice